loadpatents
Patent applications and USPTO patent grants for Wieczorek; Birgit.The latest application filed is for "egf(a) analogues with fatty acid substituents".
Patent | Date |
---|---|
Double-acylated GLP-1 derivatives Grant 11,117,947 - Wieczorek , et al. September 14, 2 | 2021-09-14 |
Double-acylated GLP-1 derivatives Grant 11,034,746 - Wieczorek , et al. June 15, 2 | 2021-06-15 |
Egf(a) Analogues With Fatty Acid Substituents App 20200407409 - Chen; Jianhe ;   et al. | 2020-12-31 |
EGF(A) analogues with fatty acid substituents Grant 10,822,385 - Chen , et al. November 3, 2 | 2020-11-03 |
Double-acylated Glp-1 Derivatives App 20200079834 - Wieczorek; Birgit ;   et al. | 2020-03-12 |
Mic-1 Compounds And Uses Thereof App 20200079829 - Gao; Xiang ;   et al. | 2020-03-12 |
HPYY(1-36) having a beta-homoarginine substitution at position 35 Grant 10,583,172 - Oestergaard , et al. | 2020-03-10 |
MIC-1 compounds and uses thereof Grant 10,398,782 - Gao , et al. Sep | 2019-09-03 |
Selective PYY compounds and uses thereof Grant 10,246,497 - Oestergaard , et al. | 2019-04-02 |
Egf(a) Analogues With Fatty Acid Substituents App 20190016768 - Chen; Jianhe ;   et al. | 2019-01-17 |
MIC-1 Compounds and Uses Thereof App 20180339057 - Gao; Xiang ;   et al. | 2018-11-29 |
FGF21 derivatives and uses thereof Grant 10,124,039 - Wieczorek , et al. November 13, 2 | 2018-11-13 |
Double-Acylated GLP-1 Derivatives App 20180251512 - Wieczorek; Birgit ;   et al. | 2018-09-06 |
FGF21 Derivatives and Uses Thereof App 20180140673 - Wieczorek; Birgit ;   et al. | 2018-05-24 |
FGF21 derivatives and uses thereof Grant 9,895,417 - Wieczorek , et al. February 20, 2 | 2018-02-20 |
FGF21 Derivatives and Uses Thereof App 20170354713 - Wieczorek; Birgit ;   et al. | 2017-12-14 |
FGF21 derivatives and uses thereof Grant 9,744,213 - Wieczorek , et al. August 29, 2 | 2017-08-29 |
Double-acylated GLP-1 derivatives Grant 9,708,383 - Madsen , et al. July 18, 2 | 2017-07-18 |
FGF21 Derivatives and Uses Thereof App 20170182124 - Wieczorek; Birgit ;   et al. | 2017-06-29 |
Double-Acylated GLP-1 Derivatives App 20170058014 - Wieczorek; Birgit ;   et al. | 2017-03-02 |
FGF21 derivatives with albumin binder A-B-C-D-E- and their use Grant 9,480,753 - Tagmose , et al. November 1, 2 | 2016-11-01 |
Selective Pyy Compounds And Uses Thereof App 20160289283 - Oestergaard; Soeren ;   et al. | 2016-10-06 |
HPYY(1-36) Having a Beta-Homoarginine Substitution at Position 35 App 20160263197 - Oestergaard; Soeren ;   et al. | 2016-09-15 |
Double-acylated Glp-1 Derivatives App 20160083447 - Wieczorek; Birgit ;   et al. | 2016-03-24 |
Double-acylated GLP-1 derivatives Grant 9,266,940 - Wieczorek , et al. February 23, 2 | 2016-02-23 |
Selective PYY compounds and uses thereof Grant 9,085,637 - Oestergaard , et al. July 21, 2 | 2015-07-21 |
Selective PYY compounds and uses thereof App 20150152150 - Oestergaard; Soeren ;   et al. | 2015-06-04 |
Double-acylated Glp-1 Derivatives App 20140088005 - Wieczorek; Birgit ;   et al. | 2014-03-27 |
Double-Acylated GLP-1 Derivatives App 20130288960 - Madsen; Alice Ravn ;   et al. | 2013-10-31 |
FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use App 20100216715 - Tagmose; Tina Moller ;   et al. | 2010-08-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.